Atlas Trials

Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome

Clinical trial NCT00946283 · TERMINATED

Trial details

NCT number
NCT00946283
Sponsor
Rutgers, The State University of New Jersey
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast CancerChronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative NeoplasmsNeuroblastomaOvarian CancerTesticular Germ Cell Tumor
Start date
2010-03-01
Primary completion
2013-05-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.